Simon Quick Advisors, LLC Moderna, Inc. Transaction History

Simon Quick Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$101.21 - $166.61 $184,202 - $303,230	1,820 New	1,820 $216,000
Q2 2022 Aug 08, 2022	SELL	$117.13 - $176.59 $6,910 - $10,418	-59 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$126.46 - $235.05 $379 - $705	3 Added 5.36%	59 $10,000
Q4 2021 Feb 08, 2022	SELL	$225.82 - $368.51 $7,677 - $12,529	-34 Reduced 37.78%	56 $14,000
Q3 2021 Oct 27, 2021	BUY	$221.9 - $484.47 $4,438 - $9,689	20 Added 28.57%	90 $34,000
Q2 2021 Jul 21, 2021	SELL	$129.91 - $234.98 $64,955 - $117,490	-500 Reduced 87.72%	70 $16,000
Q1 2021 May 06, 2021	SELL	$109.18 - $185.98 $109,180 - $185,980	-1,000 Reduced 63.69%	570 $74,000
Q4 2020 Jan 27, 2021	BUY	$65.74 - $169.86 $4,601 - $11,890	70 Added 4.67%	1,570 $164,000
Q3 2020 Oct 26, 2020	SELL	$54.34 - $94.85 $81,510 - $142,275	-1,500 Reduced 50.0%	1,500 $106,000
Q2 2020 Aug 04, 2020	BUY	$29.67 - $80.0 $44,505 - $120,000	1,500 Added 100.0%	3,000 $193,000
Q1 2020 Apr 09, 2020	BUY	$17.78 - $31.58 $26,670 - $47,370	1,500 New	1,500 $45,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Simon Quick Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Simon Quick Advisors, LLC with notifications on news.